Le Lézard
Classified in: Health, Science and technology, Business
Subject: CXP

Shield Diagnostics Receives College of American Pathology (CAP) Accreditation

SAN JOSE, Calif., Aug. 14, 2019 /PRNewswire/ -- Shield Diagnostics, an Andreessen Horowitz-backed biotechnology company tackling antibiotic resistance by bringing precision medicine to infectious disease, announced today that it has been awarded accreditation by the College of American Pathologists (CAP).

Shield Diagnostics Logo

"Receiving CAP accreditation is an important recognition of our laboratory. It means that our test results are meeting and exceeding industry standards for clinical laboratory testing," said Arthur Baca, M.D. Ph.D., Laboratory Director.

Shield Diagnostics' Chief Executive Officer, Fred Turner, upon learning of the laboratory's accreditation, said: "We are proud of our diligent and experienced clinical lab team. Their meticulous work ensures that we maintain the highest standards of excellence in laboratory practices. By providing accurate and rapid test results for the susceptibility of pathogens to less potent antibiotics, we hope to end the abuse of our last defense antibiotics."

During the CAP accreditation process, inspectors perform an on-site inspection and examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

About the College of American Pathologists

As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.

About Shield Diagnostics

Shield Diagnostics is a biotechnology company with a vision of preventing antibiotic resistance from growing deadlier than cancer.  With a mission to enable resistance-guided therapy, Shield Diagnostics is developing rapid molecular testing to target antibiotic use to the specific infection. Our first rapid molecular test, Target-NG, evaluates gonorrhea infections for antibiotic susceptibility to ciprofloxacin, as a reflex to gonorrhea, chlamydia, and trichomoniasis testing in our CLIA & CAP accredited laboratory in San Jose, CA. Currently, Shield Diagnostics is the only laboratory in the industry that offers a gonorrhea reflex test for antibiotic susceptibility to ciprofloxacin. For more information, visit https://shielddx.com/.


SOURCE Shield Diagnostics

These press releases may also interest you

at 10:54
Tosca, an innovator in reusable packaging and supply chain solutions, announced today that it is working with grocery retailer Wegmans Food Markets to ship the grocer's case-ready meat products in reusable plastic containers (RPCs). This packaging...

at 10:52
Layer1 Technologies, the first U.S. based vertically-integrated and renewable energy Bitcoin mining and factory development company, announced today that it has started mining at its Bitcoin factory in West Texas. With multiple...

at 10:51
Wedbush Securities, a leading financial services and investment banking firm headquartered in Los Angeles, California, is pleased to announce the appointment of veteran Financial Advisor, Tony May, as Managing Director, Investments. Tony joins the...

at 10:47
RoamHR (roamhr.com), the digital platform empowering the freelance workforce to easily and effectively manage its taxes, announces its partnership with BBVA Open Platform. Starting today, RoamHR users will now have access to FDIC-insured tax...

at 10:44
Finastra has brought its core banking platform, Fusion Phoenix, to the cloud, with Commerce National Bank & Trust of Winter Park, Florida, and Commencement Bank of Tacoma, Washington being the first US banks to access the core solution via public...

at 10:44
A-G Administrators, the sports insurance specialists, announced a strategic partnership with the Pennsylvania School Boards Association Insurance Trust (PSBA) today. PSBA is an organization that provides superior insurance services and programs...

News published on 14 august 2019 at 09:11 and distributed by: